Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant Disease.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 34379085.
- Also identified by DOI 10.1001/jamaoncol.2021.4381 and PMC identifier 8358793.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This retrospective case series study examines immune response of adults with hematologic malignant disease who were vaccinated with 1 of 3 FDA-authorized COVID-19 vaccines between February and April of 2021.
Medical subject headings
- Antibody Formation
- COVID-19
- COVID-19 Vaccines
- Hematologic Diseases
- Neoplasms